Get startedLog in
    Picture of Opus Genetics logo

    IRD — Opus Genetics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapMomentum Trap
    All News

    Brief: Ocuphire Pharma announces acquisition of Opus Genetics

    Picture of Opus Genetics logoOpus Genetics
    22/10/2024 22:16
    Oct 22 (Reuters) - Ocuphire Pharma Inc  OCUP.O :
    * OCUPHIRE PHARMA ANNOUNCES ACQUISITION OF OPUS GENETICS
    * OCUPHIRE PHARMA INC - PROJECTED CASH RUNWAY EXTENDED INTO
2026
    * OCUPHIRE PHARMA INC - COMBINED COMPANY TO BE RENAMED OPUS
GENETICS, TRADING AS 'IRD'
    * OCUPHIRE PHARMA INC - GEORGE MAGRATH TO CONTINUE AS CEO OF
COMBINED COMPANY
    * OCUPHIRE PHARMA INC - STOCKHOLDERS TO OWN 58%, OPUS
GENETICS
STOCKHOLDERS 42% OF COMBINED CO
    * OCUPHIRE PHARMA INC - LYNX-2 PHASE 3 TRIAL ON TRACK FOR
TOP-LINE
DATA IN Q1 2025

Source text for Eikon:  ID:nGNX4S5QNj 
Further company coverage:  OCUP.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Opus Genetics

    See all news